Sales and Marketing

Showing 15 posts of 11527 posts found.

Goldacre is right – greater honesty is needed

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …

‘Patchy’ NHS Constitution needs improving

November 7, 2012 Sales and Marketing DoH, Future Forum, NHS, commissioning

The NHS Future Forum has criticised the NHS Constitution for not being up to scratch and suggested ‘essential steps’ to …

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …

Takeda to buy Envoy Therapeutics

November 7, 2012 Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …

Pfizer backs new biotech firm

November 6, 2012 Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco

Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …

First Northern Ireland director for ABPI announced

November 6, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland

The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …

MRC gives £7 million to new projects

November 6, 2012 Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

Further US approval for Xarelto

November 5, 2012 Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto

US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …

Bayer to acquire Schiff Nutrition

November 4, 2012 Sales and Marketing Bayer, mergers and acquisitions

Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …

Pfizer stumbles in third quarter

November 2, 2012 Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012 Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

COPA-DATA appoints new UK managing director

November 2, 2012 Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams

Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012 Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

Mike Mallinson joins The Access Partnership

November 1, 2012 Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership

Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …

GSK hit by European austerity again

November 1, 2012 Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …
The Gateway to Local Adoption Series

Latest content